u/enzo_fonseca

private and NHS pathways are not a ladder, they are separate routes

say what you are actually asking, the vocabulary here is imprecise

Push back on the advice above: nobody here can tell a member what dose to take, however confidently it is phrased.

read the wiki first, then ask anyway

Has the appetite changed, even if the scale has not?

Titration is a tolerance ladder.

graph_it_gary has explained this better than the wiki does, which is saying something.

What does the wiki page on this say — genuinely asking, not deflecting?

This. Anything involving pregnancy or contraception goes to a clinician, and this board should keep saying so.

Switched pharmacies mid-titration and had to restart the ladder because the concentrations did not line up.

Cosigning on discharge at goal. It catches people who have done everything right and did not know it was coming.

Sent a vial in specifically to check a supplier’s claim after a good experience. It matched. Boring result, worth logging.

A rule-change proposal needs replacement wording because that is what can be evaluated. Without it there is nothing to compare against the current text.

Titration is a tolerance ladder.

asks_dumb_questions has explained this better than the wiki does, which is saying something.

Cosigning on saying who paid.

This is why the template has a batch field. Without it the result is about a vial nobody can identify.

a COA is a certificate of analysis, the lab document for a batch

Agreed — week two with nothing on the scale is so common it should be in the sidebar. It probably is.

Scotland, Wales and Northern Ireland have their own arrangements. An answer that begins with "in England" should say so, and most of the confusion here comes from answers that do not.

If the report gives a mass spectrum as well as UV purity, say so. Identity and relative quantity are separate claims and the log tracks both.

Proposed a rule change here with actual wording and it was adopted. That is the process working and it is not fast.

removals get explained publicly where the rule allows it

Titration is a tolerance ladder. Each step exists so the gastrointestinal effects settle before the next increase, which is why the intervals are what they are.

say whether you paid for it yourself

If the report gives a mass spectrum as well as UV purity, say so. Identity and relative quantity are separate claims and the log tracks both.

The evidence standard on the vendor boards requires a document, a date or a named service behind any claim about a supplier. It is what makes those threads worth reading years later.

Push back: PCOS as a diagnosis and insulin resistance as a finding are not interchangeable, and the thread is using them as one.

Adding the one thing nobody warns about — fertility can change, and quickly.

stability in solution is the practical question nobody asks

Bought small, tested identity first, and only then thought about anything else. That order felt right.

the injection is easier than you are imagining

Careful, that pricing figure is a headline offer with conditions attached rather than the actual monthly cost.

Took three weeks to understand titration and about ten seconds once somebody explained it as a tolerance ladder.

This is the answer. Everything else in the thread is elaboration on it.

Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.

private prescription pricing moves monthly and the pharmacy is most of the spread

Went looking for trial data on the specific question asked here and found the population had not been enrolled.

PCOS and insulin resistance are the thread that runs through this board

week two with nothing happening is normal

Agreed — and two services on one batch is the strongest thing any of us can produce individually.

Adding the boring but useful bit: say whether you paid for it. It is the basis of the whole log.

evidence rules are strict here on purpose

area percent unless the report says otherwise

What is the actual question underneath the question? Happy to answer both.

That claim traces back to a single preclinical paper that says something considerably narrower.